new glp 1 agonist GLP-1 receptor agonists show promise in treating substance use disorders Can one drug do it
Description
Imagine if you were a big drug company with shareholders, profits to lose, etc., and you just spent ~$1 billion and ~10 years to bring a drug to market
Magliano DJ, Boyko EJ, committee IDFDAtes
doi: 10.1056/NEJMoa0802743 15 CrabtreeTOgendoJ-JVinogradovaYGordonJIdrisI
GLP-1R and -actin were measured by western blot and real-time PCR
when you want longer sessions, you can adjust
Tirzepatide as compared with semaglutide for the treatment of obesity
